BWX Technologies (NYSE: BWXT) boosts 2026 outlook after strong Q2 results
Rhea-AI Filing Summary
BWX Technologies reported strong second quarter 2026 results, with revenue of $901.6 million, up 18% year over year, and GAAP net income of $89.1 million, up 14%. GAAP diluted EPS rose to $0.97, non-GAAP EPS to $1.07, and consolidated adjusted EBITDA reached $155.5 million, a 7% increase. Commercial Operations revenue grew 72% to $302.5 million, while Government Operations revenue increased 2% to $601.3 million. Free cash flow was $115.0 million versus $126.3 million a year earlier, reflecting higher capital expenditures.
The company announced the sale of its medical business to sharpen focus on nuclear national defense and commercial nuclear power, and closed the acquisition of Precision Components Group on July 1, 2026, adding a U.S. commercial nuclear manufacturing footprint. Total backlog increased to 8,398,081 (in thousands) from 6,015,191 (in thousands) a year earlier. Reflecting a strong first half and the PCG contribution, BWXT raised 2026 guidance to revenue of approximately $3,800 million, adjusted EBITDA of $662–$672 million, non-GAAP EPS of $4.70–$4.80, and free cash flow of $345–$360 million. The board declared a quarterly dividend of $0.27 per share payable September 4, 2026.
Positive
- Q2 2026 revenue rose 18% to $901.6 million, with GAAP diluted EPS up 14% to $0.97 and GAAP net income reaching $89.1 million.
- Commercial Operations revenue grew 72% to $302.5 million, helping lift consolidated adjusted EBITDA 7% to $155.5 million year over year.
- Total backlog increased to 8,398,081 (in thousands) from 6,015,191 (in thousands) a year earlier, supporting future revenue visibility.
- 2026 outlook was raised to revenue of about $3,800 million, non-GAAP EPS of $4.70–$4.80, and free cash flow of $345–$360 million.
Negative
- None.
Filing Explained
As of June 30, BWXT reported $608,203 thousand cash against $2,019,897 thousand long-term debt; the medical-business sale remained only announced.
The August 3 Form 8-K is an Item 2.02 results disclosure: it furnishes the second-quarter release, and says that release is not deemed “filed” under Section 18.
At
The release defines adjusted EBITDA, non-GAAP EPS, and free cash flow as supplemental non-GAAP measures; free cash flow starts with operating cash flow and subtracts property, plant, and equipment purchases, so the guidance figures should not be read as GAAP measures or substitutes for them.
The medical-business sale remains described as announced, not completed; this filing does not establish its consideration or closing date.
8-K Event Classification
2 items: 2.02, 9.01
2 items
Item 2.02
Results of Operations and Financial Condition
Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Q2 2026 Revenue: $901.6 million
Q2 2026 GAAP Net Income: $89.1 million
Q2 2026 Adjusted EBITDA: $155.5 million
+5 more
8 metrics
Q2 2026 Revenue
$901.6 million
Three months ended June 30, 2026; up 18% vs Q2 2025
Q2 2026 GAAP Net Income
$89.1 million
Three months ended June 30, 2026; up 14% vs $78.5 million in Q2 2025
Q2 2026 Adjusted EBITDA
$155.5 million
Consolidated adjusted EBITDA; 7% increase vs $145.9 million in Q2 2025
Q2 2026 Diluted GAAP EPS
$0.97
Diluted earnings per common share; up from $0.85 in Q2 2025
Q2 2026 Free Cash Flow
$115.0 million
Three months ended June 30, 2026; compared with $126.3 million in Q2 2025
Total Backlog
8,398,081 (in thousands)
Backlog at June 30, 2026; compared with 6,015,191 (in thousands) a year earlier
2026 Revenue Guidance
~$3,800 million
Year ending December 31, 2026 current guidance vs $3,198 million 2025 results
2026 Non-GAAP EPS Guidance
$4.70–$4.80
Year ending December 31, 2026 non-GAAP EPS guidance vs $4.01 in 2025
Key Terms
adjusted EBITDA, free cash flow, non-GAAP Earnings Per Share (EPS), advance billings on contracts, +1 more
5 terms
adjusted EBITDA financial
"2Q26 net income of $89.1 million, adjusted EBITDA(1) of $155.5 million"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
free cash flow financial
"free cash flow(1) guidance to $345 million-$360 million"
Free cash flow is the amount of money a company has left over after paying all its expenses and investing in its business, like buying equipment or updating facilities. It shows how much cash is available to reward shareholders, pay down debt, or save for future growth. This helps investors understand if a company is financially healthy and able to grow.
advance billings on contracts financial
"Contracts in progress and advance billings on contracts"
backlog financial
"BACKLOG: Government Operations $ 6,797,627"
A backlog is the amount of work or orders that a company has received but hasn't completed yet. It’s like a restaurant with many dishes to serve; the backlog shows how many orders are still waiting to be finished. It matters because a large backlog can indicate strong demand or potential delays in delivering products or services.
Earnings Snapshot
Revenue: $901.6 million · Guidance included
Quarter ended June 30, 2026
Revenue
$901.6 million
Up 18% vs $764.0 million in Q2 2025
GAAP diluted EPS
$0.97
Up 14% vs $0.85 in Q2 2025
Non-GAAP EPS
$1.07
Up 5% vs $1.02 in Q2 2025
Adjusted EBITDA
$155.5 million
Up 7% vs $145.9 million in Q2 2025
GAAP net income
$89.1 million
Up 14% vs $78.5 million in Q2 2025
Guidance
For 2026, BWXT guides to revenue of approximately $3,800 million, adjusted EBITDA of $662–$672 million, non-GAAP EPS of $4.70–$4.80, and free cash flow of $345–$360 million, all raised from prior 2026 guidance ranges.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
How did BWXT (BWXT) perform financially in Q2 2026?
BWXT reported Q2 2026 revenue of $901.6 million, up 18% year over year, and GAAP net income of $89.1 million, up 14%. GAAP diluted EPS was $0.97, while non-GAAP EPS reached $1.07, with adjusted EBITDA of $155.5 million.
How did BWXT’s Government and Commercial segments perform in Q2 2026?
In Q2 2026, BWXT’s Government Operations revenue was $601.3 million, up 2%, while Commercial Operations revenue rose 72% to $302.5 million. Government segment operating income was $105.7 million, and Commercial segment operating income was $24.3 million.
What 2026 guidance did BWXT (BWXT) provide and how was it changed?
For 2026, BWXT now guides to revenue of about $3,800 million, adjusted EBITDA of $662–$672 million, non-GAAP EPS of $4.70–$4.80, and free cash flow of $345–$360 million. All of these ranges were raised from prior 2026 guidance levels.
What strategic portfolio moves did BWXT (BWXT) highlight in this update?
BWXT announced the sale of its medical business to sharpen focus on nuclear national defense and commercial nuclear power, and closed the acquisition of Precision Components Group, LLC on July 1, 2026, establishing a U.S. footprint for commercial nuclear component manufacturing.
What were BWXT’s (BWXT) Q2 2026 cash flow and free cash flow figures?
In Q2 2026, BWXT generated operating cash flow of $156.4 million and free cash flow of $115.0 million, compared with $159.0 million and $126.3 million, respectively, in Q2 2025. Capital expenditures were $41.4 million in the quarter.
How large is BWXT’s (BWXT) current backlog and what does it indicate?
BWXT reported total backlog of 8,398,081 (in thousands) at June 30, 2026, up from 6,015,191 (in thousands) a year earlier. This higher backlog reflects contracted work in both Government and Commercial Operations and supports future revenue visibility across its nuclear-focused businesses.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________________________________________________________________
FORM 8-K
______________________________________________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 3, 2026
BWX TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
_____________________________________________________________________________
| Delaware | 001-34658 | 80-0558025 | |||||||||||||||||||||
| (State or other jurisdiction | (Commission | (IRS Employer | |||||||||||||||||||||
| of incorporation) | File Number) | Identification No.) | |||||||||||||||||||||
| 800 Main Street, 4th Floor | |||||||||||||||||||||||
| Lynchburg, | Virginia | 24504 | |||||||||||||||||||||
| (Address of principal executive offices) | (Zip Code) | ||||||||||||||||||||||
Registrant’s telephone number, including area code: (980) 365-4300
____________________________________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | ||||
Securities registered pursuant to Section 12(b) of the Act: | ||||||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
| Common Stock, $0.01 par value | BWXT | New York Stock Exchange | ||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
| Emerging growth company | ☐ | ||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On August 3, 2026, we issued a press release announcing our financial results for the second quarter ended June 30, 2026. A copy of the press release is attached as Exhibit 99.1, and the information contained in Exhibit 99.1 is incorporated by reference.
The information furnished pursuant to this Item 2.02, including Exhibit 99.1, shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| 99.1 | Earnings Release dated August 3, 2026. | |||||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | |||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| BWX TECHNOLOGIES, INC. | ||||||||
| By: | /s/ Kevin J. Gorman | |||||||
| Kevin J. Gorman | ||||||||
| Vice President and Chief Accounting Officer | ||||||||
August 3, 2026
BWX Technologies Reports Second Quarter 2026 Results
•2Q26 revenues of $901.6 million
•2Q26 net income of $89.1 million, adjusted EBITDA(1) of $155.5 million
•2Q26 diluted GAAP EPS of $0.97, non-GAAP(1) EPS of $1.07
•Announced the sale of the medical business, enabling increased focus on core nuclear national defense and commercial nuclear power markets
•Closed the acquisition of Precision Components Group, LLC (PCG) on July 1, 2026, establishing a U.S. footprint for commercial nuclear component manufacturing
•Raising adjusted EBITDA(1) guidance to $662 million-$672 million, non-GAAP EPS(1) guidance to $4.70-$4.80, and free cash flow(1) guidance to $345 million-$360 million
(LYNCHBURG, Va. - Aug. 3, 2026) BWX Technologies, Inc. (NYSE: BWXT) ("BWXT", "we", "us" or the "Company") reported second quarter 2026 results. A reconciliation of non-GAAP results is detailed in Exhibit 1.
“We had strong second quarter 2026 results that were ahead of our expectations,” said Rex. D. Geveden, president and chief executive officer. “Once again we saw strong execution across our business, high growth in Commercial Operations, and good free cash flow generation.”
“Demand for new nuclear solutions is remarkably deep and broad, complementing our strong and growing base of highly predictable revenue streams in our Government and Commercial segments,” continued Geveden. “In line with our strategy to bolster BWXT’s competitive positioning in the nuclear national security and commercial nuclear power markets, the announced sale of our medical business enables us to increase focus and resources in these core business lines. This strategy is already in action through our commercial manufacturing expansion in the U.S. and ongoing investments to drive capacity and modernization across our manufacturing footprint.”
“Reflecting our strong first half performance, contribution from the recently completed PCG acquisition, and confidence in our execution over the remainder of the year, we are raising our 2026 financial guidance,” said Geveden. “We now anticipate adjusted EBITDA of $662 million-$672 million, non-GAAP EPS of $4.70-$4.80, and $345 million-$360 million of free cash flow.”
(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.
Financial Results Summary
| Three Months Ended June 30, | ||||||||||||||||||||||||||
| 2026 | 2025 | $ Change | % Change | |||||||||||||||||||||||
| (Unaudited) (In millions, except per share amounts) | ||||||||||||||||||||||||||
| Revenues | ||||||||||||||||||||||||||
| Government Operations | $ | 601.3 | $ | 589.0 | $ | 12.3 | 2% | |||||||||||||||||||
| Commercial Operations | $ | 302.5 | $ | 176.1 | $ | 126.4 | 72% | |||||||||||||||||||
| Consolidated | $ | 901.6 | $ | 764.0 | $ | 137.6 | 18% | |||||||||||||||||||
| Operating Income | ||||||||||||||||||||||||||
| Government Operations | $ | 105.7 | $ | 109.4 | $ | (3.7) | (3)% | |||||||||||||||||||
| Commercial Operations | $ | 24.3 | $ | 6.9 | $ | 17.5 | 254% | |||||||||||||||||||
| Unallocated Corporate (Expense) | $ | (15.9) | $ | (13.9) | $ | (2.0) | 14% | |||||||||||||||||||
| Consolidated | $ | 114.1 | $ | 102.4 | $ | 11.7 | 11% | |||||||||||||||||||
Consolidated non-GAAP(1) | $ | 126.6 | $ | 121.1 | $ | 5.5 | 5% | |||||||||||||||||||
| EPS (Diluted) | ||||||||||||||||||||||||||
| GAAP | $ | 0.97 | $ | 0.85 | $ | 0.12 | 14% | |||||||||||||||||||
Non-GAAP(1) | $ | 1.07 | $ | 1.02 | $ | 0.05 | 5% | |||||||||||||||||||
| Net Income | ||||||||||||||||||||||||||
| GAAP | $ | 89.1 | $ | 78.5 | $ | 10.6 | 14% | |||||||||||||||||||
Non-GAAP(1) | $ | 98.6 | $ | 93.2 | $ | 5.5 | 6% | |||||||||||||||||||
Adjusted EBITDA(1) | ||||||||||||||||||||||||||
| Government Operations | $ | 126.5 | $ | 133.0 | $ | (6.5) | (5)% | |||||||||||||||||||
| Commercial Operations | $ | 36.1 | $ | 16.2 | $ | 20.0 | 123% | |||||||||||||||||||
| Unallocated Corporate | $ | (7.1) | $ | (3.3) | $ | (3.8) | 116% | |||||||||||||||||||
| Consolidated | $ | 155.5 | $ | 145.9 | $ | 9.6 | 7% | |||||||||||||||||||
| Cash Flows | ||||||||||||||||||||||||||
Operating Cash Flow(2) | $ | 156.4 | $ | 159.0 | $ | (2.6) | (2)% | |||||||||||||||||||
Capital Expenditures(2) | $ | 41.4 | $ | 32.7 | $ | 8.7 | 27% | |||||||||||||||||||
Free Cash Flow(1) | $ | 115.0 | $ | 126.3 | $ | (11.3) | (9)% | |||||||||||||||||||
Dividends Paid(2) | $ | 24.7 | $ | 23.1 | $ | 1.5 | 6% | |||||||||||||||||||
NM = Not Meaningful
(2) Items named in the Financial Results Summary differ from names in BWXT Financial Statement. Operating Cash Flow = Net Cash Provided by Operating Activities; Capital Expenditures = Purchases of Property, Plant and Equipment; Dividends Paid = Dividends Paid to Common Shareholders
Revenues
Second quarter revenue increased in both operating segments. The Government Operations increase was driven by growth in naval propulsion and special materials, partially offset lower advanced nuclear volumes. The Commercial Operations increase was driven by growth in commercial nuclear components, field services, fuel handling, medical, and contribution from Kinectrics, partially offset by slightly lower fuel revenue.
Operating Income and Adjusted EBITDA(1)
Second quarter GAAP operating income increased primarily due to growth in Commercial Operations, partially offset by lower Government Operations and higher corporate expense.
Second quarter non-GAAP(1) operating income increased driven by growth in Commercial Operations, partially offset by lower Government Operations and higher corporate expense. The Commercial Operations increase was driven by higher revenue and solid operational performance, partially offset by
(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.
SG&A investment to support growth. The decrease in Government Operations was driven by higher positive contract adjustments in the same quarter last year and less favorable mix, partially offset by higher technical services equity income.
Second quarter adjusted EBITDA(1) increased due to higher non-GAAP(1) operating income as discussed above.
EPS
Second quarter GAAP and non-GAAP(1) EPS increased as higher operating income and lower interest expense were partially offset by lower other income and a higher tax rate.
Cash Flows
Second quarter operating cash flow was modestly lower as higher net income, an increase in advanced billings, and good working capital management were offset by timing of income tax payments. Capital expenditures increased mainly due to timing of various growth projects, primarily in Commercial Operations.
Dividend
BWXT paid $24.7 million, or $0.27 per common share, to shareholders in the second quarter of 2026. On July 31, 2026, the BWXT Board of Directors declared a quarterly cash dividend of $0.27 per common share payable on September 4, 2026, to shareholders of record on August 18, 2026.
2026 Guidance
BWXT raised its 2026 guidance for revenue, adjusted EBITDA, non-GAAP EPS(1), and free cash flow(1). 2026 guidance includes contribution from the Precision Components Group, LLC acquisition, which closed on July 1, 2026.
| (In millions, except per share amounts) | Year Ended | Year Ending | Year Ending | ||||||||||||||||||||
| December 31, 2025 | December 31, 2026 | December 31, 2026 | |||||||||||||||||||||
| Results | Current Guidance | Prior Guidance | |||||||||||||||||||||
| Revenue | $3,198 | ~$3,800 | >$3,750 | ||||||||||||||||||||
Adjusted EBITDA(1) | $574 | $662 - $672 | $650 - $665 | ||||||||||||||||||||
Non-GAAP(1) Earnings Per Share | $4.01 | $4.70 - $4.80 | $4.60 - $4.75 | ||||||||||||||||||||
Free Cash Flow(1) | $295 | $345 - $360 | $315 - $330 | ||||||||||||||||||||
Additional information can be found in the second quarter 2026 earnings call presentation on the BWXT investor relations website at www.bwxt.com/investors. The Company does not provide GAAP guidance because it is unable to reliably forecast most of the items that are excluded from GAAP to calculate non-GAAP results. These items could cause GAAP results to differ materially from non-GAAP results.
Conference Call to Discuss Second Quarter 2026 Results
Date: Monday, August 3, 2026, at 5:00 p.m. EDT
Live Webcast: Investor Relations section of website at www.bwxt.com
Full Earnings Release Available on BWXT Website
A full version of this earnings release is available on our Investor Relations website at http://investors.bwxt.com/2Q2026-release.
BWXT may use its website (www.bwxt.com) as a channel of distribution of material Company information. Financial and other important information regarding BWXT is routinely accessible through and posted on our website. In addition, you may elect to automatically receive e-mail alerts and other information about BWXT by enrolling through the “Email Alerts” section of our website at http://investors.bwxt.com.
(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.
Non-GAAP Measures
BWXT uses and makes reference to adjusted EBITDA, non-GAAP EPS, free cash flow and free cash flow conversion, which are not recognized measures under GAAP. BWXT is providing these non-GAAP measures to supplement the results provided in accordance with GAAP and it should not be considered superior to, or as a substitute for, the comparable GAAP measures. BWXT believes the non-GAAP measures provide meaningful insight and transparency into the Company’s operational performance and provides these measures to investors to help facilitate comparisons of operating results with prior periods and to assist them in understanding BWXT's ongoing operations. Definitions for the non-GAAP measures are provided below and reconciliations are detailed in Exhibit 1, except that reconciliations of forward-looking GAAP measures are not provided because the company is unable to reliably forecast most of the items that are excluded from GAAP to calculate non-GAAP results. Other companies may define these measures differently or may utilize different non-GAAP measures, thus impacting comparability.
Non-GAAP Earnings Per Share (EPS) is calculated using GAAP EPS less the non-operational tax effected per share impact of pension & OPEB mark-to-market gains or losses and other one-time items, such as restructuring, transformation, acquisition-related costs, and acquisition-related amortization.
Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) is calculated using non-GAAP net income, plus provision for income taxes, less other – net, less interest income, plus interest expense, plus depreciation and amortization.
Adjusted pre-tax income is non-GAAP income before provision for income taxes.
Free Cash Flow (FCF) is calculated using net income to derive net cash provided by (used in) operating activities less purchases of property, plant and equipment.
Free Cash Flow conversion is free cash flow divided by net income.
Non-GAAP Adjustments
Our GAAP financial results detailed in Exhibit 1 have been adjusted for the following items:
Restructuring and Transformation Costs: Restructuring and transformation costs include restructuring charges as well as costs associated with our efforts to optimize underlying business processes through investments in information technology, process improvements and the implementation of strategic actions and initiatives which we deem to be incremental and non-recurring in nature.
Acquisition-related Costs: Acquisition-related costs relate to third-party professional service costs and one-time incremental costs associated with due diligence activities and efforts to integrate the acquired business with our legacy operations.
Forward-Looking Statements
BWXT cautions that this release contains forward-looking statements, including, without limitation, statements relating to backlog, to the extent they may be viewed as an indicator of future revenues; our plans and expectations for each of our reportable segments, including growth opportunities and the expectations, timing and revenue of our strategic initiatives, such as medical radioisotopes, SMR components and recent acquisitions; disruptions to our supply chain and/or operations, changes in government regulations and other factors; and our expectations and guidance for 2026 and beyond. These forward-looking statements are based on management’s current expectations and involve a number of risks and uncertainties, including, among other things, our ability to execute contracts in backlog; federal budget uncertainty, the risk of future budget cuts, the impact of continuing resolution funding mechanisms and the debt ceiling, the potential for government shutdowns and changing funding and acquisition priorities; the demand for and competitiveness of nuclear products and services; capital priorities of power
(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.
generating utilities and other customers; the timing of technology development, regulatory approvals and automation of production; the receipt and/or timing of government approvals; the potential recurrence of subsequent waves or strains of COVID-19 or similar diseases; labor market challenges, including employee retention and recruitment; adverse changes in the industries in which we operate; and delays, changes or termination of contracts in backlog. If one or more of these risks or other risks materialize, actual results may vary materially from those expressed. For a more complete discussion of these and other risk factors, see BWXT’s filings with the Securities and Exchange Commission, including our annual report on Form 10-K for the year ended December 31, 2025 and subsequent Form 10-Q filings. BWXT cautions not to place undue reliance on these forward-looking statements, which speak only as of the date of this release, and undertakes no obligation to update or revise any forward-looking statement, except to the extent required by applicable law.
About BWXT
At BWX Technologies, Inc. (NYSE: BWXT), we are People Strong, Innovation Driven. A U.S.-based company with more than 11,000 employees, BWXT is a Fortune 1000 and Defense News Top 100 manufacturing and engineering innovator that provides safe and effective nuclear solutions for global security, clean energy, nuclear medicine, space exploration and environmental restoration. BWXT owns and operates 19 manufacturing facilities globally, and its 14 strategic partnerships support the U.S. and Canadian governments at more than two dozen additional locations.
For more information, visit www.bwxt.com. Follow us on LinkedIn, X, Facebook and Instagram.
| Investor Contact: | Media Contact: | |||||||||||||
| Chase Jacobson | John Dobken | |||||||||||||
| Vice President, Investor Relations | Senior Manager, Media & Public Relations | |||||||||||||
| 980-365-4300 | Investors@bwxt.com | 202-428-6913 | jcdobken@bwxt.com | |||||||||||
(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.
EXHIBIT 1
BWX TECHNOLOGIES, INC.
RECONCILIATION OF NON-GAAP OPERATING INCOME AND EARNINGS PER SHARE(1)(2)(3)
(In millions, except per share amounts)
| Three Months Ended June 30, 2026 | |||||||||||||||||||||||||||||
| GAAP | Restructuring & Transformation Costs | Acquisition-Related Costs | Acquisition-Related Amortization | Non-GAAP | |||||||||||||||||||||||||
| Government Operations Operating Income | $ | 105.7 | $ | — | $ | — | $ | 1.1 | $ | 106.8 | |||||||||||||||||||
| Commercial Operations Operating Income | $ | 24.3 | $ | 2.1 | $ | 0.8 | $ | 1.5 | $ | 28.7 | |||||||||||||||||||
| Unallocated Corporate Operating Income | $ | (15.9) | $ | 4.1 | $ | 2.9 | $ | — | $ | (8.9) | |||||||||||||||||||
| Operating Income | $ | 114.1 | $ | 6.2 | $ | 3.7 | $ | 2.5 | $ | 126.5 | |||||||||||||||||||
| Other - net | (0.5) | — | — | — | (0.5) | ||||||||||||||||||||||||
| Income Before Provision for Income Taxes | 113.6 | 6.2 | 3.7 | 2.5 | 126.1 | ||||||||||||||||||||||||
| Provision for Income Taxes | (24.5) | (1.5) | (0.9) | (0.6) | (27.5) | ||||||||||||||||||||||||
| Net Income | 89.1 | 4.8 | 2.9 | 1.9 | 98.6 | ||||||||||||||||||||||||
| Net Income Attributable to Noncontrolling Interest | (0.1) | — | — | — | (0.1) | ||||||||||||||||||||||||
| Net Income Attributable to BWXT | $ | 89.0 | $ | 4.8 | $ | 2.9 | $ | 1.9 | $ | 98.5 | |||||||||||||||||||
| Diluted Shares Outstanding | 92.0 | 92.0 | |||||||||||||||||||||||||||
| Diluted Earnings per Common Share | $ | 0.97 | $ | 0.05 | $ | 0.03 | $ | 0.02 | $ | 1.07 | |||||||||||||||||||
| Effective Tax Rate | 21.6% | 21.8% | |||||||||||||||||||||||||||
| Three Months Ended June 30, 2025 | |||||||||||||||||||||||||||||
| GAAP | Restructuring & Transformation Costs | Acquisition-Related Costs | Acquisition-Related Amortization | Non-GAAP | |||||||||||||||||||||||||
| Government Operations Operating Income | $ | 109.4 | $ | 0.9 | $ | 3.5 | $ | 1.8 | $ | 115.6 | |||||||||||||||||||
| Commercial Operations Operating Income | $ | 6.9 | $ | 1.0 | $ | 2.1 | $ | 0.7 | $ | 10.6 | |||||||||||||||||||
| Unallocated Corporate Operating Income | $ | (13.9) | $ | 7.1 | $ | 1.7 | $ | — | $ | (5.1) | |||||||||||||||||||
| Operating Income | $ | 102.4 | $ | 9.0 | $ | 7.2 | $ | 2.5 | $ | 121.1 | |||||||||||||||||||
| Other Income (Expense) | (4.7) | — | — | — | (4.7) | ||||||||||||||||||||||||
| Income Before Provision for Income Taxes | 97.8 | 9.0 | 7.2 | 2.5 | 116.5 | ||||||||||||||||||||||||
| Provision for Income Taxes | (19.3) | (1.4) | (2.0) | (0.6) | (23.3) | ||||||||||||||||||||||||
| Net Income | 78.5 | 7.6 | 5.3 | 1.9 | 93.2 | ||||||||||||||||||||||||
| Net Income Attributable to Noncontrolling Interest | (0.1) | — | — | — | (0.1) | ||||||||||||||||||||||||
| Net Income Attributable to BWXT | $ | 78.4 | $ | 7.6 | $ | 5.3 | $ | 1.9 | $ | 93.1 | |||||||||||||||||||
| Diluted Shares Outstanding | 91.7 | 91.7 | |||||||||||||||||||||||||||
| Diluted Earnings per Common Share | $ | 0.85 | $ | 0.08 | $ | 0.06 | $ | 0.02 | $ | 1.02 | |||||||||||||||||||
| Effective Tax Rate | 19.7% | 20.0% | |||||||||||||||||||||||||||
(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.
EXHIBIT 1 (continued)
RECONCILIATION OF CONSOLIDATED ADJUSTED EBITDA(1)(2)(3)
(In millions)
| Three Months Ended June 30, 2026 | |||||||||||||||||||||||||||||
| GAAP | Restructuring & Transformation Costs | Acquisition-related Costs | Acquisition-related Amortization | Non-GAAP | |||||||||||||||||||||||||
| Net Income | $ | 89.1 | $ | 4.8 | $ | 2.9 | $ | 1.9 | $ | 98.6 | |||||||||||||||||||
| Provision for Income Taxes | 24.5 | 1.5 | 0.9 | 0.6 | 27.5 | ||||||||||||||||||||||||
| Other – net | (0.3) | — | — | — | (0.3) | ||||||||||||||||||||||||
| Interest Expense | 5.3 | — | — | — | 5.3 | ||||||||||||||||||||||||
| Interest Income | (4.5) | — | — | — | (4.5) | ||||||||||||||||||||||||
| Depreciation & Amortization | 31.4 | — | — | (2.5) | 28.9 | ||||||||||||||||||||||||
| Adjusted EBITDA | $ | 145.5 | $ | 6.2 | $ | 3.7 | $ | — | $ | 155.5 | |||||||||||||||||||
| Three Months Ended June 30, 2025 | |||||||||||||||||||||||||||||
| GAAP | Restructuring & Transformation Costs | Acquisition-related Costs | Acquisition-related Amortization | Non-GAAP | |||||||||||||||||||||||||
| Net Income | $ | 78.5 | $ | 7.6 | $ | 5.3 | $ | 1.9 | $ | 93.2 | |||||||||||||||||||
| Provision for Income Taxes | 19.3 | 1.4 | 2.0 | 0.6 | 23.3 | ||||||||||||||||||||||||
| Other – net | (6.5) | — | — | — | (6.5) | ||||||||||||||||||||||||
| Interest Expense | 11.7 | — | — | — | 11.7 | ||||||||||||||||||||||||
| Interest Income | (0.6) | — | — | — | (0.6) | ||||||||||||||||||||||||
| Depreciation & Amortization | 27.3 | — | — | (2.5) | 24.8 | ||||||||||||||||||||||||
| Adjusted EBITDA | $ | 129.7 | $ | 9.0 | $ | 7.2 | $ | — | $ | 145.9 | |||||||||||||||||||
RECONCILIATION OF REPORTING SEGMENT ADJUSTED EBITDA(1)(2)(3)(4)
(In millions)
| Three Months Ended June 30, 2026 | ||||||||||||||||||||||||||||||||
| Operating Income (GAAP) | Non-GAAP Adjustments(3,4) | Acquisition-related Amortization | Depreciation & Amortization | Adjusted EBITDA | ||||||||||||||||||||||||||||
| Government Operations | $ | 105.7 | $ | — | $ | 1.1 | $ | 19.7 | $ | 126.5 | ||||||||||||||||||||||
| Commercial Operations | $ | 24.3 | $ | 3.0 | $ | 1.5 | $ | 7.4 | $ | 36.1 | ||||||||||||||||||||||
| Unallocated Corporate | $ | (15.9) | $ | 6.9 | $ | — | $ | 1.8 | $ | (7.1) | ||||||||||||||||||||||
| Three Months Ended June 30, 2025 | |||||||||||||||||||||||||||||||||||
| Operating Income (GAAP) | Non-GAAP Adjustments(3,4) | Acquisition-related Amortization | Depreciation & Amortization | Adjusted EBITDA | |||||||||||||||||||||||||||||||
| Government Operations | $ | 109.4 | $ | 4.4 | $ | 1.8 | $ | 17.4 | $ | 133.0 | |||||||||||||||||||||||||
| Commercial Operations | $ | 6.9 | $ | 3.1 | $ | — | $ | 6.2 | $ | 16.2 | |||||||||||||||||||||||||
| Unallocated Corporate | $ | (13.9) | $ | 8.8 | $ | — | $ | 1.8 | $ | (3.3) | |||||||||||||||||||||||||
(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.
EXHIBIT 1 (continued)
RECONCILIATION OF CONSOLIDATED FREE CASH FLOW(1)(2)(3)
(In millions)
| Three Months Ended June 30, 2026 | ||||||||
| Net Cash Provided By Operating Activities | $ | 156.4 | ||||||
| Purchases of Property, Plant and Equipment | (41.4) | |||||||
| Free Cash Flow | $ | 115.0 | ||||||
| Three Months Ended June 30, 2025 | ||||||||
| Net Cash Provided By Operating Activities | $ | 159.0 | ||||||
| Purchases of Property, Plant and Equipment | (32.7) | |||||||
| Free Cash Flow | $ | 126.3 | ||||||
| (1) | Tables may not foot due to rounding. | ||||||||||||||||||||||||||||||||||||||||||||||
| (2) | BWXT is providing non-GAAP information regarding certain of its historical results and guidance on future earnings per share to supplement the results provided in accordance with GAAP and it should not be considered superior to, or as a substitute for, the comparable GAAP measures. BWXT believes the non-GAAP measures provide meaningful insight and transparency into the Company’s operational performance and provides these measures to investors to help facilitate comparisons of operating results with prior periods and to assist them in understanding BWXT's ongoing operations. | ||||||||||||||||||||||||||||||||||||||||||||||
| (3) | For Non-GAAP adjustment details, see reconciliation of non-GAAP operating income and earnings per share. | ||||||||||||||||||||||||||||||||||||||||||||||
| (4) | Excludes acquisition-related amortization | ||||||||||||||||||||||||||||||||||||||||||||||
(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.
BWX TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
| Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||||||
| (Unaudited) (In thousands, except share and per share amounts) | ||||||||||||||||||||||||||
| Revenues | $ | 901,625 | $ | 764,039 | $ | 1,761,842 | $ | 1,446,297 | ||||||||||||||||||
| Costs and Expenses: | ||||||||||||||||||||||||||
| Cost of operations | 699,320 | 572,642 | 1,362,169 | 1,089,707 | ||||||||||||||||||||||
| Research and development costs | 4,167 | 4,565 | 8,266 | 6,578 | ||||||||||||||||||||||
(Gain) loss on asset disposals and impairments, net | (2) | 13 | 123 | (4,418) | ||||||||||||||||||||||
| Selling, general and administrative expenses | 108,432 | 102,940 | 216,448 | 190,509 | ||||||||||||||||||||||
| Total Costs and Expenses | 811,917 | 680,160 | 1,587,006 | 1,282,376 | ||||||||||||||||||||||
| Equity in Income of Investees | 24,428 | 18,545 | 45,993 | 35,133 | ||||||||||||||||||||||
| Operating Income | 114,136 | 102,424 | 220,829 | 199,054 | ||||||||||||||||||||||
| Other Income (Expense): | ||||||||||||||||||||||||||
| Interest income | 4,474 | 551 | 9,388 | 1,273 | ||||||||||||||||||||||
| Interest expense | (5,283) | (11,741) | (10,016) | (19,735) | ||||||||||||||||||||||
| Other – net | 267 | 6,525 | 710 | 8,984 | ||||||||||||||||||||||
| Total Other Income (Expense) | (542) | (4,665) | 82 | (9,478) | ||||||||||||||||||||||
Income before Provision for Income Taxes | 113,594 | 97,759 | 220,911 | 189,576 | ||||||||||||||||||||||
| Provision for Income Taxes | 24,496 | 19,297 | 40,622 | 35,588 | ||||||||||||||||||||||
| Net Income | $ | 89,098 | $ | 78,462 | $ | 180,289 | $ | 153,988 | ||||||||||||||||||
| Net Income Attributable to Noncontrolling Interest | (84) | (74) | (205) | (138) | ||||||||||||||||||||||
| Net Income Attributable to BWX Technologies, Inc. | $ | 89,014 | $ | 78,388 | $ | 180,084 | $ | 153,850 | ||||||||||||||||||
| Earnings per Common Share: | ||||||||||||||||||||||||||
| Basic: | ||||||||||||||||||||||||||
| Net Income Attributable to BWX Technologies, Inc. | $ | 0.97 | $ | 0.86 | $ | 1.96 | $ | 1.68 | ||||||||||||||||||
| Diluted: | ||||||||||||||||||||||||||
| Net Income Attributable to BWX Technologies, Inc. | $ | 0.97 | $ | 0.85 | $ | 1.96 | $ | 1.68 | ||||||||||||||||||
| Shares used in the computation of earnings per share: | ||||||||||||||||||||||||||
| Basic | 91,720,867 | 91,542,967 | 91,692,421 | 91,568,526 | ||||||||||||||||||||||
| Diluted | 92,007,253 | 91,702,703 | 91,957,928 | 91,788,204 | ||||||||||||||||||||||
(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.
BWX TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| Six Months Ended June 30, | ||||||||||||||
| 2026 | 2025 | |||||||||||||
| (Unaudited) (In thousands) | ||||||||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||||||||
| Net Income | $ | 180,289 | $ | 153,988 | ||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||||
| Depreciation and amortization | 60,375 | 51,171 | ||||||||||||
| Income of investees, net of dividends | (15,925) | (2,700) | ||||||||||||
(Gain) loss on asset disposals and impairments - net | 123 | (4,418) | ||||||||||||
| Recognition of losses for pension and postretirement plans | 1,958 | 1,627 | ||||||||||||
| Stock-based compensation expense | 20,117 | 13,735 | ||||||||||||
| Other, net | 4,451 | (9,366) | ||||||||||||
| Changes in assets and liabilities, net of effects from acquisitions: | ||||||||||||||
| Accounts receivable | 6,691 | (465) | ||||||||||||
| Accounts payable | 71,430 | 6,875 | ||||||||||||
| Retainages | (15,992) | (7,045) | ||||||||||||
| Contracts in progress and advance billings on contracts | (35,408) | 7,754 | ||||||||||||
| Income taxes | 670 | 22,558 | ||||||||||||
| Accrued and other current liabilities | (4,228) | 19,382 | ||||||||||||
| Pension liabilities, accrued postretirement benefit obligations and employee benefits | (36,448) | (33,656) | ||||||||||||
| Other, net | 10,900 | (9,747) | ||||||||||||
| NET CASH PROVIDED BY OPERATING ACTIVITIES | 249,003 | 209,693 | ||||||||||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||||||||
| Purchases of property, plant and equipment | (83,937) | (66,098) | ||||||||||||
| Acquisition of businesses, net of cash acquired | — | (538,184) | ||||||||||||
| Sales and maturities of securities | — | 3,397 | ||||||||||||
| Investments, net of return of capital, in equity method investees | (180) | (33,000) | ||||||||||||
| Other, net | (322) | 4,405 | ||||||||||||
| NET CASH USED IN INVESTING ACTIVITIES | (84,439) | (629,480) | ||||||||||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||||||||
| Borrowings of long-term debt | — | 758,400 | ||||||||||||
| Repayments of long-term debt | — | (284,650) | ||||||||||||
| Repurchases of common stock | — | (30,000) | ||||||||||||
| Dividends paid to common shareholders | (50,444) | (46,798) | ||||||||||||
| Cash paid for shares withheld to satisfy employee taxes | (19,532) | (12,883) | ||||||||||||
| Settlements of forward contracts, net | 10,263 | 1,657 | ||||||||||||
| Other, net | 2,715 | 100 | ||||||||||||
| NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES | (56,998) | 385,826 | ||||||||||||
| EFFECTS OF EXCHANGE RATE CHANGES ON CASH | 1,503 | (2,475) | ||||||||||||
TOTAL INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS | 109,069 | (36,436) | ||||||||||||
| CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD | 507,204 | 80,571 | ||||||||||||
| CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS AT END OF PERIOD | $ | 616,273 | $ | 44,135 | ||||||||||
| SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: | ||||||||||||||
| Cash paid during the period for: | ||||||||||||||
| Interest | $ | 17,505 | $ | 30,036 | ||||||||||
| Income taxes (net of refunds) | $ | 38,329 | $ | 11,890 | ||||||||||
| SCHEDULE OF NON-CASH INVESTING ACTIVITY: | ||||||||||||||
| Accrued capital expenditures included in accounts payable | $ | 20,832 | $ | 15,575 | ||||||||||
(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.
BWX TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
ASSETS
| June 30, 2026 | December 31, 2025 | |||||||||||||
| (Unaudited) (In thousands) | ||||||||||||||
| Current Assets: | ||||||||||||||
| Cash and cash equivalents | $ | 608,203 | $ | 499,779 | ||||||||||
| Restricted cash and cash equivalents | 3,120 | 3,085 | ||||||||||||
| Accounts receivable – trade, net | 198,251 | 220,391 | ||||||||||||
| Accounts receivable – other | 88,979 | 67,858 | ||||||||||||
| Retainages | 62,303 | 46,311 | ||||||||||||
| Contracts in progress | 652,011 | 610,315 | ||||||||||||
| Inventories | 46,293 | 46,537 | ||||||||||||
| Other current assets | 50,877 | 66,078 | ||||||||||||
| Total Current Assets | 1,710,037 | 1,560,354 | ||||||||||||
| Property, Plant and Equipment, Net | 1,603,188 | 1,585,136 | ||||||||||||
| Investments | 8,828 | 8,243 | ||||||||||||
| Goodwill | 494,922 | 500,860 | ||||||||||||
| Deferred Income Taxes | 5,882 | 12,275 | ||||||||||||
| Investments in Unconsolidated Affiliates | 164,708 | 150,143 | ||||||||||||
| Intangible Assets | 311,773 | 329,859 | ||||||||||||
| Other Assets | 123,792 | 124,625 | ||||||||||||
| TOTAL ASSETS | $ | 4,423,130 | $ | 4,271,495 | ||||||||||
(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.
BWX TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
LIABILITIES AND STOCKHOLDERS' EQUITY
| June 30, 2026 | December 31, 2025 | |||||||||||||
| (Unaudited) (In thousands, except share and per share amounts) | ||||||||||||||
| Current Liabilities: | ||||||||||||||
| Accounts payable | 212,881 | 141,289 | ||||||||||||
| Accrued employee benefits | 86,290 | 117,641 | ||||||||||||
| Accrued liabilities – other | 100,844 | 107,802 | ||||||||||||
| Advance billings on contracts | 313,256 | 305,285 | ||||||||||||
| Total Current Liabilities | 713,271 | 672,017 | ||||||||||||
| Long-Term Debt | 2,019,897 | 2,015,983 | ||||||||||||
| Accumulated Postretirement Benefit Obligation | 77,902 | 78,460 | ||||||||||||
| Environmental Liabilities | 103,880 | 100,278 | ||||||||||||
| Pension Liability | 69,344 | 78,167 | ||||||||||||
| Other Liabilities | 104,687 | 93,578 | ||||||||||||
| Total Liabilities | 3,088,981 | 3,038,483 | ||||||||||||
| Commitments and Contingencies | ||||||||||||||
| Stockholders' Equity: | ||||||||||||||
Common stock, par value $0.01 per share, authorized 325,000,000 shares; issued 129,006,562 and 128,720,819 shares at June 30, 2026 and December 31, 2025, respectively | 1,289 | 1,288 | ||||||||||||
Preferred stock, par value $0.01 per share, authorized 75,000,000 shares; No shares issued | — | — | ||||||||||||
| Capital in excess of par value | 183,530 | 159,884 | ||||||||||||
| Retained earnings | 2,653,709 | 2,523,631 | ||||||||||||
Treasury stock at cost, 37,384,981 and 37,289,582 shares at June 30, 2026 and December 31, 2025, respectively | (1,452,744) | (1,432,943) | ||||||||||||
Accumulated other comprehensive loss | (51,334) | (19,373) | ||||||||||||
| Stockholders' Equity – BWX Technologies, Inc. | 1,334,450 | 1,232,487 | ||||||||||||
| Noncontrolling interest | (301) | 525 | ||||||||||||
| Total Stockholders' Equity | 1,334,149 | 1,233,012 | ||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ | 4,423,130 | $ | 4,271,495 | ||||||||||
(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.
BWX TECHNOLOGIES, INC.
BUSINESS SEGMENT INFORMATION
| Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||||||
| (Unaudited) (In thousands) | ||||||||||||||||||||||||||
| REVENUES: | ||||||||||||||||||||||||||
| Government Operations | $ | 601,291 | $ | 588,959 | $ | 1,179,191 | $ | 1,144,246 | ||||||||||||||||||
| Commercial Operations | 302,512 | 176,139 | 586,158 | 304,449 | ||||||||||||||||||||||
| Eliminations | (2,178) | (1,059) | (3,507) | (2,398) | ||||||||||||||||||||||
| TOTAL | $ | 901,625 | $ | 764,039 | $ | 1,761,842 | $ | 1,446,297 | ||||||||||||||||||
| SEGMENT INCOME: | ||||||||||||||||||||||||||
| Government Operations | $ | 105,678 | $ | 109,417 | $ | 204,819 | $ | 207,163 | ||||||||||||||||||
| Commercial Operations | 24,332 | 6,877 | 48,361 | 13,342 | ||||||||||||||||||||||
| SUBTOTAL | $ | 130,010 | $ | 116,294 | $ | 253,180 | $ | 220,505 | ||||||||||||||||||
| Unallocated Corporate | (15,874) | (13,870) | (32,351) | (21,451) | ||||||||||||||||||||||
| TOTAL | $ | 114,136 | $ | 102,424 | $ | 220,829 | $ | 199,054 | ||||||||||||||||||
| DEPRECIATION AND AMORTIZATION: | ||||||||||||||||||||||||||
| Government Operations | $ | 20,758 | $ | 19,222 | $ | 39,290 | $ | 37,318 | ||||||||||||||||||
| Commercial Operations | 8,819 | 6,243 | 17,567 | 10,262 | ||||||||||||||||||||||
| Corporate | 1,785 | 1,794 | 3,518 | 3,591 | ||||||||||||||||||||||
| TOTAL | $ | 31,362 | $ | 27,259 | $ | 60,375 | $ | 51,171 | ||||||||||||||||||
| CAPITAL EXPENDITURES: | ||||||||||||||||||||||||||
| Government Operations | $ | 15,546 | $ | 15,770 | $ | 42,644 | $ | 34,270 | ||||||||||||||||||
| Commercial Operations | 24,011 | 16,701 | 38,296 | 29,910 | ||||||||||||||||||||||
| Corporate | 1,874 | 258 | 2,997 | 1,918 | ||||||||||||||||||||||
| TOTAL | $ | 41,431 | $ | 32,729 | $ | 83,937 | $ | 66,098 | ||||||||||||||||||
| BACKLOG: | ||||||||||||||||||||||||||
| Government Operations | $ | 6,797,627 | $ | 4,435,593 | $ | 6,797,627 | $ | 4,435,593 | ||||||||||||||||||
| Commercial Operations | 1,600,454 | 1,579,598 | 1,600,454 | 1,579,598 | ||||||||||||||||||||||
| TOTAL | $ | 8,398,081 | $ | 6,015,191 | $ | 8,398,081 | $ | 6,015,191 | ||||||||||||||||||
| BOOKINGS: | ||||||||||||||||||||||||||
| Government Operations | $ | 467,619 | $ | 1,412,286 | $ | 2,435,263 | $ | 1,638,683 | ||||||||||||||||||
| Commercial Operations | 181,251 | 228,195 | 463,967 | 721,615 | ||||||||||||||||||||||
| TOTAL | $ | 648,870 | $ | 1,640,481 | $ | 2,899,230 | $ | 2,360,298 | ||||||||||||||||||
(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.